Irbit Chemical Pharmaceutical Plant

Irbit Chemical Pharmaceutical Plant (IHFP) is a major Russian pharmaceutical manufacturer based in Irbit, Sverdlovsk Oblast. Established in 1941 following the evacuation of chemical facilities during World War II, the company has evolved into a key producer of finished dosage forms and active pharmaceutical ingredients (APIs). Its product portfolio includes over 60 items across various therapeutic areas such as cardiology, neurology, and gastroenterology, with a strong emphasis on essential medicines like ibuprofen and metformin. The facility operates under GMP standards and is a core manufacturing asset of the Avexima pharmaceutical group. IHFP plays a critical role in the Russian government's import substitution program for vital medicines.